Search
Maze Therapeutics Inc
MAZEAdd to Watchlist
31.200USD
+0.190+0.61%
Market hours 10/26, 10:42（ET）
1.68BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.61%
5 Days
+13.33%
1 Month
+19.77%
6 Months
+20.88%
Year to Date
-24.69%
1 Year
+2.67%
Key Figures
31.005Open
31.860High
3.22KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
31.010Prev. Close
30.540Low
100.38KTurnover
494.16P/E Static
3.71P/B
0.00%Div Yield TTM
-32.57%ROA
53.65052wk High
0.02Volume Ratio
3.40MNet Profit
53.93MShares
-2.3549EPS TTM
--Beta
-38.67%ROE
21.95052wk Low
4.26%Amplitude
100.00%Gross Margin
1.68BMarket Cap
-1.16Reward/Risk
4.27%Risk Rate
More news coming soon, stay tuned...
Maze Therapeutics Inc's Score
-0.06vs previous score
Forecast8.86
Financial Health9.20
Technical5.12
Valuation Dimensions8.48
Institutional Confidence10.00
Risk Assessment4.91
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Maze Therapeutics Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.76/-0.73
Revenue / Forecast
0.00/2.00M
Maze Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolMAZE
Number of employees125
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Third Rock Ventures, LLC | 9.80% |
| Frazier Life Sciences Management, L.P. | 8.25% |
| Deep Track Capital LP | 7.67% |
| ARCH Venture Partners | 7.44% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 29.53% |
| Hedge Fund | 22.51% |
| Investment Advisor/Hedge Fund | 17.37% |
| Investment Advisor | 14.65% |
Related Instruments
+0.60%
+1.74%
+0.76%
-1.14%
+1.69%
-0.02%
+1.59%
+1.89%
+0.06%
-0.08%
-1.32%
-0.10%
+0.26%
+0.67%
+0.39%
+0.78%
-1.40%
+1.28%
+1.75%
+0.33%Popular Instruments
52532.200
+264.100 (+0.51%)
29240.500
+231.300 (+0.80%)
7679.600
+45.500 (+0.60%)
13048.000
+113.000 (+0.87%)
62918.000
+396.000 (+0.63%)
6125.800
+66.300 (+1.09%)
100.440
-2.746 (-2.66%)
345.710
-2.015 (-0.58%)
215.620
+4.660 (+2.21%)
4022.180
+27.410 (+0.69%)
FAQs
What is the current price of Maze Therapeutics Inc (MAZE)?
The current price of Maze Therapeutics Inc (MAZE) is 31.01.
What is the symbol of Maze Therapeutics Inc?
The ticker symbol of Maze Therapeutics Inc is MAZE.
What is the 52-week high of Maze Therapeutics Inc?
The 52-week high of Maze Therapeutics Inc is 53.65.
What is the 52-week low of Maze Therapeutics Inc?
The 52-week low of Maze Therapeutics Inc is 21.95.
What is the market capitalization of Maze Therapeutics Inc?
The market capitalization of Maze Therapeutics Inc is 1.67B.
Is Maze Therapeutics Inc (MAZE) currently rated as Buy, Hold, or Sell?
According to analysts, Maze Therapeutics Inc (MAZE) has an overall rating of Buy, with a price target of 62.27.
What is the Earnings Per Share (EPS TTM) of Maze Therapeutics Inc (MAZE)?
The Earnings Per Share (EPS TTM) of Maze Therapeutics Inc (MAZE) is -2.35.